Paolo Guglielmi

Pubblicazioni

Titolo Pubblicato in Anno
Novel insights on saccharin- and acesulfame-based carbonic anhydrase inhibitors: design, synthesis, modelling investigations and biological activity evaluation JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2020
Natural compounds and extracts as novel antimicrobial agents EXPERT OPINION ON THERAPEUTIC PATENTS 2020
Synthesis and biological evaluation of carvacrol-based derivatives as dual inhibitors of H. Pylori strains and ags cell proliferation PHARMACEUTICALS 2020
Innovative pH-interfering agents in association with anticancer agents pH-Interfering Agents as Chemosensitizers in Cancer Therapy 2020
Design, synthesis, docking studies and monoamine oxidase inhibition of a small library of 1-acetyl- and 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazoles MOLECULES 2019
4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2019
Novel therapies for glaucoma: a patent review (2013-2019) EXPERT OPINION ON THERAPEUTIC PATENTS 2019
The up-regulation of oxidative stress as a potential mechanism of novel MAO-B inhibitors for glioblastoma treatment MOLECULES 2019
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2019
Benzo[b]tiophen-3-ol derivatives as effective inhibitors of human monoamine oxidase: design, synthesis, and biological activity JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2019
Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement? EXPERT OPINION ON DRUG DISCOVERY 2019
Kinesin Eg5 targeting inhibitors as a new strategy for gastric adenocarcinoma treatment MOLECULES 2019
Mechanisms of action of carbonic anhydrase inhibitors: compounds that bind “out of the binding site” and compounds with an unknown mechanism of action Carbonic Anhydrases Biochemistry and Pharmacology of an Evergreen Pharmaceutical Target 2019
Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2018
Magnetic metal−organic framework composite by fast and facile mechanochemical process INORGANIC CHEMISTRY 2018
Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2018
Enantiomers of triclabendazole sulfoxide: analytical and semipreparative HPLC separation, absolute configuration assignment, and transformation into sodium salt JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 2017
Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2017
Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2017
Protective effects Induced by microwave-assisted aqueous harpagophytum extract on rat cortex synaptosomes challenged with amyloid β-peptide PHYTOTHERAPY RESEARCH 2017

ERC

  • PE5_18

KET

  • Advanced materials
  • Life-science technologies & biotechnologies

Interessi di ricerca

  • Design e sintesi di inibitori delle monoaminoossidasi umane (hMAO-A / hMAO-B).
  • Design e sintesi di inibitori selettivi delle isoforme IX e XII dell’anidrasi carbonica umana (hCA IX, hCA XII) implicate nei tumori.
  • Design e sintesi di farmaci antitumorali inibitori della chinesina Eg5.
  • Sviluppo e sintesi di metal-organic frameworks (MOFs) per applicazioni biomediche.

Ulteriori interessi di ricerca:

  • Impiego delle microonde nella sintesi chimica (molecole biologicamente attive, MOF) o per estrazioni di principi attivi da matrici vegetali (MAE).
  • Estrazione, purificazione e caratterizzazione di anticorpi monoclonali da matrici vegetali.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma